We are live on ! Find out more
RS

R Squared Portfolio holdings

AUM $182M
1-Year Est. Return 18.52%
This Fund
S&P 500
This Quarter Est. Return
+2.25%
1 Year Est. Return
+18.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$182M
AUM Growth
-$31.9M
Cap. Flow
-$30.2M
Cap. Flow %
-16.61%
Top 10 Hldgs %
17.47%
Holding
696
New
183
Increased
134
Reduced
159
Closed
219

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.9M
2
HOLX
Hologic
HOLX
+$4.77M
3
TXNM
TXNM Energy Inc
TXNM
+$3.68M
4
TSLA icon
Tesla
TSLA
+$2.33M
5
LLY icon
Eli Lilly
LLY
+$2.06M

Top Sells

Rank Stock Value
1
FYBR
Frontier Communications
FYBR
+$5.48M
2
LIN icon
Linde
LIN
+$4.58M
3
BLK icon
Blackrock
BLK
+$3.51M
4
MSI icon
Motorola Solutions
MSI
+$3.35M
5
TSM icon
TSMC
TSM
+$2.24M

Sector Composition

Rank Sector Weight
1 Financials 17.61%
2 Industrials 17.14%
3 Technology 15.62%
4 Healthcare 13.23%
5 Consumer Discretionary 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEW
351
GrabAGun Digital Holdings
PEW
$71.4M
$120K 0.07%
39,926
-5,353
-12% -$16.2K
ARDT
352
Ardent Health
ARDT
$1.48B
$120K 0.07%
+13,971
New +$125K
DNN icon
353
Denison Mines
DNN
$2.71B
$118K 0.06%
33,460
+17,659
+112% +$66.4K
SMRT icon
354
SmartRent
SMRT
$187M
$118K 0.06%
78,481
+31,503
+67% +$53.2K
LCID icon
355
Lucid Motors
LCID
$2.82B
$116K 0.06%
12,177
-11,288
-48% -$117K
DNUT icon
356
Krispy Kreme
DNUT
$543M
$115K 0.06%
34,012
+11,029
+48% +$38.1K
ALLO icon
357
Allogene Therapeutics
ALLO
$632M
$110K 0.06%
45,245
-40,970
-48% -$82.1K
ARCO icon
358
Arcos Dorados Holdings
ARCO
$1.76B
$108K 0.06%
13,117
-1,095
-8% -$8.89K
EWCZ
359
DELISTED
European Wax Center
EWCZ
$108K 0.06%
18,661
-11,825
-39% -$58.9K
STLA icon
360
Stellantis
STLA
$16.7B
$106K 0.06%
+15,001
New +$126K
LXRX icon
361
Lexicon Pharmaceuticals
LXRX
$1.03B
$105K 0.06%
67,526
+20,947
+45% +$30.5K
GGB icon
362
Gerdau
GGB
$9.17B
$104K 0.06%
+28,939
New +$114K
HLLY icon
363
Holley
HLLY
$317M
$103K 0.06%
33,606
+18,497
+122% +$70.1K
BULL
364
Webull Corp
BULL
$4.3B
$103K 0.06%
21,438
-3,707
-15% -$24K
GRFS
365
Grifois
GRFS
$5.23B
$101K 0.06%
12,611
-10,844
-46% -$95.6K
CVRX icon
366
CVRx
CVRX
$131M
$99.8K 0.05%
10,551
+121
+1% +$885
RXRX icon
367
Recursion Pharmaceuticals
RXRX
$1.6B
$99.4K 0.05%
32,363
+11,118
+52% +$43K
SVCO
368
Silvaco Group
SVCO
$293M
$99.1K 0.05%
+13,994
New +$62.9K
OPEN icon
369
Opendoor
OPEN
$4.17B
$98.6K 0.05%
21,061
-4,746
-18% -$25.6K
AMC icon
370
AMC Entertainment Holdings
AMC
$2.04B
$98.2K 0.05%
100,186
+77,906
+350% +$100K
BCYC
371
Bicycle Therapeutics
BCYC
$290M
$97.7K 0.05%
+21,057
New +$120K
RNW icon
372
ReNew
RNW
$2.28B
$96.1K 0.05%
20,984
-17,248
-45% -$91.8K
BBAI icon
373
BigBear.ai
BBAI
$1.4B
$95.6K 0.05%
27,171
-17,030
-39% -$79.1K
IOVA icon
374
Iovance Biotherapeutics
IOVA
$2.33B
$94.4K 0.05%
26,883
-7,650
-22% -$24.5K
TLRY icon
375
Tilray
TLRY
$522M
$94.1K 0.05%
+14,543
New +$113K

Similar funds

R Squared's Q1 2026 Portfolio in Review

As of Q1 2026, R Squared held 696 positions worth $182M, down 15% from $214M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

R Squared withdrew a net $30.2M in Q1 2026, closing 219 positions and reducing 159 holdings. Its most notable exit was Frontier Communications, an estimated $5.48M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.

Against the trend, R Squared opened a new position in Apple worth $4.78M.

  • R Squared's largest Q1 2026 buy was Apple: 18,818 shares worth $4.78M.
  • R Squared added most to Hologic in Q1 2026, an estimated $4.77M increase.
  • R Squared's biggest Q1 2026 reduction was Linde, cutting an estimated $4.58M.
  • R Squared fully exited Frontier Communications in Q1 2026, selling an estimated $5.48M.
  • R Squared's ten largest holdings make up 17% of its $182M portfolio in Q1 2026.
  • R Squared opened 183 new positions and closed 219 in Q1 2026.
  • R Squared's portfolio value fell 15% quarter-over-quarter to $182M.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.